Third, Crest software was applied to detect a total of 743 SVs in 20 samples of cervical adenocarcinoma, revealing 34 fusion genes (e.g., HLA-H-HLA-A, APOL4-APOL1, and LINC00893-LINC00894), all with a positive rate among all samples of 15%. This evidence concerns the gene EOLA2-DT and cervical adenocarcinoma.